Canada: Look Before You Leap: Pre-Canadian Launch Regulatory Considerations For U.S. Companies

Deciding whether or not to launch a food, drug, medical device, dietary supplement or cosmetic product in Canada involves a number of considerations, including:

  • whether regulatory approval is needed for the product;
  • if regulatory approval is required, timing the approval with the launch of the product and the Canadian operations;
  • whether to establish a business corporation in Canada or to outsource or partner for the distribution of the Canadian product;
  • how to price the product;
  • how to protect your brand and market in Canada; and
  • whether your U.S. agreements, labeling and product support will suffice for the Canadian market.

Regulatory Approvals

In Canada, food, drugs, medical devices, dietary supplements (in Canada, known as "natural health products" or NHPs), and cosmetics are regulated federally by Health Canada (Canada's version of the U.S. Food and Drug Administration) and governed by Canada's Food and Drugs Act and Regulations.

For drugs, including over-the counter and NHPs, and most medical devices1, a manufacturer must obtain a license from Health Canada before the product may be sold. Cosmetics and certain classes of foods are subject to notification and must be manufactured and marketed in accordance with detailed legislation and government policies.

There are differences between licensing requirements in Canada and the U.S. For example, NHPs, generally akin to dietary supplements in the U.S., are regulated as a type of drug in Canada and are subject to "drug"-related standards rather than "food"-related standards. Medical devices are categorized into four different risk classes in Canada, so a manufacturer cannot assume that a device will have the same risk classification in Canada and the U.S.

Timing to obtain regulatory approval is a key consideration for your Canadian launch. The time required to obtain a product license varies according to a product's classification and its complexity. Lower-risk medical device licenses typically take one to two months to obtain, while higher-risk medical device licenses typically take four to six months or more. The approval process for new drug submissions can take several years. The time required to receive a natural health product license in Canada is typically three months for standard submissions, but can be significantly longer for products with several active ingredients.

Coordinating the timing of the regulatory approval with the launch of the Canadian product and Canadian operations can be tricky. To minimize the risk of costs associated with operations before a product has regulatory approval, usually there is a lag between regulatory approval and launch. Most manufacturers want the certainty of the Canadian regulatory approval before the other operational processes required for the launch of the Canadian product—hiring employees, leasing space, etc..

A regulatory application filed with the U.S. FDA is usually a good start for preparing a corresponding product license application for Canada, although some changes to the U.S. application will likely be needed, particularly with respect to the mandatory label requirements.

In addition to product licensing requirements, Canadian facilities may also require an establishment or site license to permit the manufacture, sale, import or distribution of regulated products. Although the obligations of a license holder vary depending on the class of product, these facility licenses generally require that internal policies relating to good manufacturing practices, recall procedures, complaint handling and record keeping be in place at each facility where products are handled.

Where the product is manufactured outside of Canada, and after the product has its regulatory approval, most manufacturers will test their import, warehousing and distribution in Canada through a trial run to ensure that the product is not held up at the border and that distribution of the product through the supply chain is smooth.

Establishing A Business In Canada

Many options exist for structuring your business operations in Canada, including: establishing a relationship with a Canadian partner that will be responsible for regulatory approvals, sales, marketing and distribution in Canada; establishing a Canadian subsidiary of a U.S. corporation; or handling most operations from the U.S. and running Canadian operations from the U.S. office, with outsourcing to Canadian third parties where required.

A business presence in Canada can provide significant advantages for your company. For example, there are federal and provincial refundable tax credits for basic science and clinical research conducted in Canada (Scientific Research and Experimental Development, or SRED, credits) for certain operating expenses and capital expenditures, which, depending on the province, can be as high as 60%.2 Many other provincial grants are provided for early-stage companies. For example, there are loans and grants specially geared to companies operating in the food, drug and medical device spaces, as well as grants available to companies that create at least 100 jobs or invest C$25 million locally.

In Canada, taxes on goods and services can apply at both provincial and federal levels. It is important to understand how Canadian sales taxes apply and who is responsible for collecting them. For example, the manufacturer, importer, distributor, reseller or end user may be required to remit the applicable tax, depending on your particular situation. Establishing a business presence in Canada may require your Canadian operation to file a Canadian income tax return with the Canada Revenue Agency (CRA).

Product Pricing

Because of the proximity of Canada to the U.S. market, an important consideration is the pricing of your regulated product. Differential pricing, whether through product pricing or through currency exchanges, can create gray marketing or can result in cross-border sales that may interfere with your plans for product distribution and sales. Pricing of certain products may be reviewed and controlled by federal bodies, including the Competition Bureau and the Patented Medicine Prices Review Board (PMPRB). The PMPRB is unique to Canada and regulates the price for which patented drugs are sold, based in part on the price that an equivalent drug is sold in other jurisdictions.

Advertising And Promotional Activities

Drugs, medical devices and NHPs require regulatory approval before you can advertise their availability for sale in Canada. Prescription drug product advertising varies greatly in the U.S. and Canada, with Canadian promotion to the general public being very limited with no therapeutic claims.3 here are also restrictions on advertising of any product as a treatment for certain diseases, such as diabetes, cancer and hypertension4.

Food advertisements and label claims are also regulated. Canada has relatively strict rules with respect to the types of disease-reduction claims (for example, "a healthy diet low in sodium and high in potassium can reduce risk of high blood pressure"), and functional claims (for example, "calcium aids in the formation and maintenance of bones and teeth"). Products that are promoted for use in a "healthy" lifestyle can be subject to greater scrutiny.

Marketing and promotional practices at conferences or trade shows are subject to specific Canadian rules. For example, the distribution of drug and natural health product samples to the general public is not permissible.5 When food samples are provided free to consumers, labeling must comply with the Food and Drug Regulations, such as the inclusion of a Nutrition Facts table, if applicable.

Because of the unique advertising regulations, your company website may require some changes to promote your product to Canadian residents. For example, you may need to create a Canadian-specific portion of your main website if your approved Canadian claims differ from the U.S. claims, or if you have products that are not yet approved for sale in Canada but are available in other jurisdictions. Additionally, if you plan to sell your product in Quebec as well as support its sale in the province (e.g., having a French language website) you may wish to consider French language compliance rules.

It can be advantageous to obtain a Canadian domain name, with the ".ca" suffix. According to the Canadian Internet Registration Authority, over 60% of Canadians prefer using a domain with a .ca suffix for online shopping6. To obtain this domain name, the registrant must have a connection to Canada, meaning that the registrant must be a Canadian citizen, a permanent resident or a Canadian corporation—so this should be a consideration for establishing a business presence in Canada. Provided the requirements to obtain a .ca domain name are met, the name can be purchased from a domain name registrar approved by the Canadian Internet Registration Authority.

Canadian Marketing Standards And Codes

With respect to prescription drugs, most oversight of the marketing practices of manufacturers has been undertaken by the pharmaceutical industry itself, through complaints to bodies such as: (i) the Pharmaceutical Advertising Advisory Board (PAAB), which reviews advertising directed at health care professionals under its Code of Advertising Acceptance; (ii) Rx&D, the innovator industry trade association, which has established a Code of Ethical Practices; and (iii) the Canadian Generic Pharmaceutical Association (CGPA), through the administration of the Code of Marketing Conduct Governing the Sale of Generic Pharmaceutical Products in Canada. There are several other industry associations that have developed ethical codes and guidelines, including the national medical technology industry group MEDEC, Food Beverage Canada and BIOTECanada. These codes are considered to be "industry standard" and therefore many Canadian companies will voluntarily adhere to the codes, whether or not they are actually members of the applicable organizations.

Canadian advertising industry bodies, such as Advertising Standards Canada (ASC) and the Television Bureau of Canada (TVB) provide pre-clearance services for various types of consumer advertising presented through Canadian media, including radio, TV, newspapers, magazines, billboard, flyers and internet. These bodies will review advertisements for compliance with the Food and Drugs Act, as well as their own compliance codes. Although pre-clearance by these bodies is generally not a legal requirement, in practice broadcasters will not run advertisements, particularly for NHPS, drug and medical device products that have not been approved by these bodies.

Branding – Selecting Your Trademark

It is important to take steps to protect your trademark in Canada, especially if you have already invested efforts to protect your brand in the United States. Obtaining a Canadian trademark registration provides trademark protection across all Canadian provinces and territories. Obtaining Canadian protection as soon as possible can minimize the possibility of a competitor aware of your brand in the United States filing for a registration in Canada, which would preclude your registration and restrict how you may be able to use your brand in Canada.

An application for a trademark in Canada is filed with the Canadian Intellectual Property Office (similar to the U.S. Patent and Trademark Office) and in some situations, priority claims can be made to an earlier U.S. trademark application.

Patents – Don't Forget Canada

For companies whose products are innovative, the innovations relating to the products are typically covered in patents and patent applications. There can be strategic issues associated with the filing and prosecution of your Canadian patent applications, regulatory approvals and launch. In the pharmaceutical and biotechnology section, regulations provide for the listing of patents on Health Canada's patent register (the Canadian counterpart to the U.S. Orange Book). However, if the patent application is filed in Canada after the date of the regulatory submission, the patent is not listable against that regulatory submission, even if the patent meets the other criteria for listability. In all sectors, failing to proactively prosecute the Canadian application to issuance will have the result that the patent is not enforceable against competitors until the patent issues. The result can be that competitors are on the market and your patents cannot be leveraged until they are issued. For that reason, it is helpful to dovetail the patent strategy with the preparation and launch of the Canadian product.

Adverse Reaction Reporting And Product Liability

Your company should be aware of its obligations under the Food and Drugs Act, and its regulations, to report adverse reactions related to your product. he regulations for each product class differ and a manufacturer selling in Canada may also be required to report adverse reactions to Health Canada that occur in other jurisdictions.

The Canada Vigilance Program is Health Canada's post-market surveillance program that collects and assesses reports of suspected adverse reactions to health products marketed in Canada, including drugs and medical devices. The Canadian Food Inspection Agency and Health Canada's Consumer Product Safety Directorate manage recalls for foods and cosmetics, respectively. Information relating to adverse reactions and recalls is available through the Canadian government's online resources.

As in other jurisdictions, the sale of your product in Canada may place your company at risk for product liability claims, including class-action proceedings which are on the rise. To succeed in a product liability suit, a consumer would need to show that the product in question was in some way defective, either in its manufacture or design. An assessment of whether the product is defective will typically involve a review of the risks and benefits of the product. This review can subsequently form the basis for the determination of other issues, such as the appropriate warnings that the manufacturer had a duty to convey. Accordingly, to reduce the likelihood of product liability claims, you should ensure that any applicable product documentation, package labeling and instruction materials transparently inform the user of any risks or deficiencies inherent in the product and its use or consumption.

Privacy Protection For Canadians

If you are planning to obtain personal information or personal health information from Canadians, it is important to ensure that your privacy policy, websites and any contracts or other agreements you have in place with Canadians comply with Canadian law. Canada has both federal and provincial privacy laws, and it can be a challenge to determine which law applies in a particular situation.

In general, organizations must obtain the knowledgeable consent of an individual for the collection, use and disclosure of his or her personal information. The Canadian Privacy Commissioner has voiced concern over the personal information of Canadians being transferred outside Canada, where Canadian privacy laws may no longer apply (especially regarding storing personal information in the United States). An organization should therefore consider whether additional measures must be taken if personal information is to be transferred from within Canada to another jurisdiction, for example, for processing or cloud storage.

In addition, Canada has recently enacted "anti-spam" legislation that applies to commercial electronic messages, including emails, text, instant messaging, and social media notifications. This legislation will be in force July 1, 2014, and non-compliance could result in monetary penalties of millions of dollars per violation.

French Language Requirements

Canada has two official languages: English and French. English is the dominant language throughout most of Canada; French is the official language of the province of Quebec, and the province of New Brunswick is officially bilingual. With very limited exceptions, Quebec's provincial laws require advertising, packaging, instruction manuals, customer support and troubleshooting, as well as other services to be made available in French. For example, if a product is offered for sale in Quebec, labeling must include French content, and if a product is advertised on the manufacturer or vendor's .ca website, the website must also be available in French. Quebec is one of Canada's largest provinces, so these provincial laws may have an important impact not only on advertising, but also on how you provide support and other services to residents of Quebec.

Originally published in FDLI's Update.


1. Class I medical devices, the lowest risk class for devices in Canada, are exempt from the requirement to obtain a medical device license; however, manufacturers of these devices require a medical device establishment license before they can sell or advertise for sale any such medical device in Canada.

2. Moreover, banks will advance loans on the basis of estimated refundable SRED credits. Claims for SRED credits are made to the Canada Revenue Agency (CRA) at the same time as filing a Canadian income tax return.

3. Promotion of a prescription drug (Schedule F) to the general public is limited to name, price and quantity (Section C.01.044 of the Food and Drug Regulations).

4. For a complete list, see Schedule A of the Canadian Food and Drugs Act available at (

5. Section 14 of the Food and Drugs Act prohibits the distribution of drug samples other than to a physician, dentist, veterinary surgeon or pharmacist (a "health care professional"). Accordingly, it is not permissible to distribute NHP samples direct to consumers.

6. See

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.